Table 3.
Association between treatment and change in methylation markers from baseline to week 24.
| Model§ | Estimate (95% CI) | P-value |
|---|---|---|
| change in SAM from baseline to week 24* | 1.186 (−1.009, 3.381) | 0.2892 |
| change in SAH from baseline to week 24* | 0.810 (0.000, 1.621) | 0.0501 |
| change in SAM/SAH from baseline to week 24* | −103.110 (−261.568, 55.348) | 0.2021 |
Box-Cox transformation was applied to models that violated normality assumption.
Placebo and male groups were used as reference groups. Models adjusted for gender, age at baseline, baseline value of specific DNA methylation marker, baseline creatinine and baseline GFR.